Thursday, October 4, 2012- Medical Device Mayhemat Motley Fool (Thu, Oct 4)
- This Big Pharma Pair Parts Waysat Motley Fool (Thu, Oct 4)
- Johnson & Johnson settles Risperdal cases over breast growth in boysat bizjournals.com (Thu, Oct 4)
- Johnson & Johnson Agrees to Settle Five Rispersal Suitsat Bloomberg (Thu, Oct 4)
- Tissue Regenix Stock Jumps on Wound-Healing Test Resultsat Bloomberg (Thu, Oct 4)
- A Plea For Open Science In Medicineat Forbes (Thu, Oct 4)
- Former FDA chief says J&J broke law promoting Risperdal, Philly Inquirer saystheflyonthewall.com (Thu, Oct 4)
- Was Billionaire Ackman Right To Sell Citigroup, Buy Procter & Gamble?at Seeking Alpha (Thu, Oct 4)
Wednesday, October 3, 2012- Nothing's Inhibiting This Drug -- Yetat Motley Fool (Wed, Oct 3)
- Celgene's Pipeline Offers Catalysts Into 2013at Seeking Alpha (Wed, Oct 3)
- Getting The Dividend Bus Rollingat Seeking Alpha (Wed, Oct 3)
- Too Many MBAs Heading to Wall Street?at CNBC (Wed, Oct 3)
- For Dividend Growth Investors - Now Is Not The Time To Buyat Seeking Alpha (Wed, Oct 3)
- Generate Retirement Income With Dividend Stocksat Seeking Alpha (Wed, Oct 3)
- Avon Products Will Have To Cut Dividendsat Seeking Alpha (Wed, Oct 3)
- Opko's 4KScore Could Generate Over $1.8 Billion Annuallyat Seeking Alpha (Wed, Oct 3)
- Five Cheap and Solid Dividend Stocksat Motley Fool (Wed, Oct 3)
- 4 Attractively Valued Dividend Stocks To Considerat Seeking Alpha (Wed, Oct 3)
- HP Inks 5 Year Contract with Rolls-Royce and 3 Dow Movers to Trackat Wall St. Cheat Sheet (Wed, Oct 3)
- The Good, The Bad And The Ugly: Johnson & Johnsonat Seeking Alpha (Wed, Oct 3)
Tuesday, October 2, 2012Add JNJ News to My Yahoo!   | |
|
0.64(0.73%) May 17, 4:02PM EDT|After Hours
:
88.38